Abstract:Active vitamin D-1.25OHD (1,25Dihydroxyvitamin D, calcitriol) in the endometrium of women with endometriosis seems to be enhanced compared to healthy controls. Evidence is insufficient on how this process reflects vitamin D metabolites-25OHD (25 Hydroxyvitamin D, calcifediol), 1.25OHD, and calcium blood concentrations. Aim: Determination of vitamin D's significance in the pathogenesis of endometriosis by analyzing the levels of 25OHD, 1.25OHD, and calcium in patients with endometriosis before and after laparoscopic treatment. Materials and methods: This study is an anterograde comparative analysis, that investigates the variation of vitamin D metabolite and calcium levels between the preoperative assessment and the subsequent measurement following surgical treatment of endometriosis. Results before the intervention were also compared to the healthy control group. Levels of 25OHD,1.25OHD, and calcium before required surgical treatment and 3 months post-laparoscopy were measured. Data analyses were made using IBM SPSS 27. Results: Women with endometriosis have significantly lower mean 25OHD (p-0.002) and a higher 1.25OHD (p<0.001) and total calcium levels (p-0.03) compared to controls. The endometriosis stage and size of endometrioma negatively correlate with 25OHD levels (p<0.001). After surgical removal of endometriotic lesions, 1.25OHD, and calcium showed a significant decrease whereas 25OHD blood concentrations increased statistically significantly. Conclusion: Women with endometriosis have a lower 25OHD, a higher 1.25OHD, and total calcium levels in the bloodstream compared to the control group. Usually, a low concentration of 25OHD is characterized by low/normal 1.25OHD and hypocalcemia. Hypercalcemia in the study group may be attributed to increased levels of active vitamin D- 1.25OHD, which seems to be the result of a higher conversion rate of 25OHD to 1.25OHD in the endometrium of women with endometriosis. Removal of endometriotic heterotopies was followed by significant changes, which could indicate that the levels of vitamin D metabolites have been influenced by endometriosis. It is reasonable to conclude, that diminished levels of 25OHD might be interpreted as an outcome of a high demand in endometriosis, instead of a risk factor.

1–Alpha, 25–Dihydroxyvitamin D3 Regresses Endometriotic Implants in Rats by Inhibiting Neovascularization and Altering Regulation of Matrix Metalloproteinase

Effect of PRL-3 inhibitor on the ectopic lesions in rats with endometriosis

Research Progress on Roles of Vitamin D in Endometriosis

Enhanced Expressions of Matrix Metalloproteinase (Mmp)-2 And-9 and Vascular Endothelial Growth Factors (vegf) and Increased Microvascular Density in the Endometrial Hyperplasia of Women with Anovulatory Dysfunctional Uterine Bleeding

Pigment Epithelial-Derived Factor Expression in Endometriotic Lesions in a Rat Model of Endometriosis.

Antiangiogenic Agents Are Effective Inhibitors of Endometriosis

Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells in Vitro

LOW 25OHD IN ENDOMETRIOSIS- RISK FACTOR OR CONSEQUENCE?!

Effect of Recombinant Human Endostatin on Endometriosis in Mice

Effect on Activating Blood and Removing Stasis Prescription on E2、P、VEGF of Endometriotic Rats

The Broad-Spectrum Chemokine Inhibitor NR58-3.14.3 Suppresses the Implantation and Survival of Human Endometrial Implants in the Nude Mice Endometriosis Model

Valproic Acid and Progestin Inhibit Lesion Growth and Reduce Hyperalgesia in Experimentally Induced Endometriosis in Rats

Vascular endothelial growth factor and matrix metalloproteinase-2 expedite formation of endometriosis in the early stage ICR mouse model.

Vitamin D3 reduces the symptoms of ovarian hyperstimulation syndrome in mice and inhibits the release of granulosa cell angiogenic factor through pentraxin 3

25(OH)D3 improves granulosa cell proliferation and IVF pregnancy outcomes in patients with endometriosis by increasing G2M+S phase cells

The Role of VEGF and MMP-2 in the Early Stage of Evolution of Endometriosis

Antiproliferative Effects of 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells

Therapeutic Effect of Letrozole in Rats with Endometriosis

The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis

Efficacy of Colchicine and Melatonin in the treatment of rat endometriosis model: an animal study

Vitamin D—The Iceberg in Endometriosis—Review and Meta-Analysis